Transcat, Inc. (NASDAQ:TRNS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Transcat, Inc. (NASDAQ:TRNS - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five analysts that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $127.25.

A number of research analysts have recently issued reports on the stock. Northland Securities dropped their price target on shares of Transcat from $130.00 to $110.00 and set a "market perform" rating on the stock in a research report on Wednesday, October 30th. Craig Hallum decreased their target price on Transcat from $138.00 to $113.00 and set a "buy" rating for the company in a research note on Wednesday, October 30th. Oppenheimer reissued an "outperform" rating and issued a $130.00 price target (down from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. HC Wainwright reaffirmed a "buy" rating and set a $156.00 price objective on shares of Transcat in a research report on Tuesday, October 29th. Finally, StockNews.com lowered shares of Transcat from a "hold" rating to a "sell" rating in a research note on Tuesday, October 29th.

Institutional Trading of Transcat

Several hedge funds have recently bought and sold shares of the business. Conestoga Capital Advisors LLC boosted its stake in Transcat by 17.9% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company's stock valued at $109,561,000 after purchasing an additional 137,830 shares during the last quarter. Royce & Associates LP lifted its holdings in shares of Transcat by 8.2% in the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company's stock valued at $61,798,000 after purchasing an additional 38,774 shares in the last quarter. Champlain Investment Partners LLC boosted its position in shares of Transcat by 22.1% during the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company's stock valued at $49,455,000 after buying an additional 74,169 shares during the last quarter. Hood River Capital Management LLC grew its holdings in Transcat by 21.6% during the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company's stock worth $23,558,000 after buying an additional 34,947 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its position in Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company's stock valued at $9,577,000 after buying an additional 17,743 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

Transcat Price Performance

NASDAQ TRNS traded up $0.28 on Thursday, reaching $108.03. The company had a trading volume of 89,383 shares, compared to its average volume of 55,071. The firm has a market cap of $993.88 million, a price-to-earnings ratio of 54.56 and a beta of 0.69. Transcat has a fifty-two week low of $89.39 and a fifty-two week high of $147.12. The business has a 50 day moving average of $118.56 and a two-hundred day moving average of $121.68.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). The company had revenue of $67.83 million during the quarter, compared to analyst estimates of $70.30 million. Transcat had a net margin of 6.63% and a return on equity of 7.36%. The company's quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.41 EPS. As a group, research analysts predict that Transcat will post 1.76 earnings per share for the current fiscal year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.